A diet deficient in calcium was considered the highest risk factor, linked to approximately one in five deaths from colon ...

Stomach cancer is the fifth most common cancer worldwide, often undiagnosed until advanced stages. Recognising persistent ...

A dad-of-three from Co Down was diagnosed with stomach cancer after a year of subtle symptoms. Now cancer-free, he is urging ...

Research shows that people with a certain body shape face a higher risk of serious health problems compared to their ...

Researchers compare nivolumab as monotherapy or in combination with chemotherapy vs conventional treatment on overall survival and progression-free survival in patients with advanced unresectable ...

Adding intraperitoneal paclitaxel to intravenous paclitaxel and oral S-1 improved survival in patients with gastric cancer and peritoneal metastasis.

Adding evorpacept to treatment with trastuzumab, ramucirumab, and paclitaxel may improve outcomes in HER2-positive gastric/GEJ cancer.

CheckMate 649 trial showed sustained efficacy with frontline nivolumab plus chemotherapy vs chemotherapy alone in patients with gastric cancers.